# High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension

> **NCT03474562** · PHASE4 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 100 (actual)

## Conditions studied

- ASCVD
- Impaired Fasting Glucose
- Hypertension

## Interventions

- **DRUG:** Duowell®
- **DRUG:** Monorova® + Amlopin®

## Key facts

- **NCT ID:** NCT03474562
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-03
- **Primary completion:** 2019-06-07
- **Final completion:** 2019-06-07
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2021-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03474562

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03474562, "High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03474562. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*